Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics.

Natarajan A, Gruettner C, Ivkov R, DeNardo GL, Mirick G, Yuan A, Foreman A, DeNardo SJ.

Bioconjug Chem. 2008 Jun;19(6):1211-8. doi: 10.1021/bc800015n. Epub 2008 Jun 3.

PMID:
18517234
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice.

DeNardo SJ, DeNardo GL, Natarajan A, Miers LA, Foreman AR, Gruettner C, Adamson GN, Ivkov R.

J Nucl Med. 2007 Mar;48(3):437-44.

PMID:
17332622
[PubMed - indexed for MEDLINE]
Free Article
3.

Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression.

Ito A, Honda H, Kobayashi T.

Cancer Immunol Immunother. 2006 Mar;55(3):320-8. Epub 2005 Aug 25. Review.

PMID:
16133113
[PubMed - indexed for MEDLINE]
4.

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Wang YX, Hussain SM, Krestin GP.

Eur Radiol. 2001;11(11):2319-31. Review.

PMID:
11702180
[PubMed - indexed for MEDLINE]
5.

Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer.

Goodman GE, Hellstrom I, Yelton DE, Murray JL, O'Hara S, Meaker E, Zeigler L, Palazollo P, Nicaise C, Usakewicz J, et al.

Cancer Immunol Immunother. 1993;36(4):267-73.

PMID:
8382560
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk